The massive (mis)use of antibiotics to control infections in aquaculture has resulted in the development of resistant strains, which have rendered antibiotic treatments ineffective. Moreover, the horizontal transfer of resistance determinants to human pathogens and the presence of antibiotic residues in aquaculture products for human consumption constitute important threats to public health. Therefore, to make the aquaculture industry more sustainable, new strategies to control infections are urgently needed.
Introduction
Aquaculture comprises all forms of culture of aquatic animals and plants in fresh, brackish and marine environments [1] . Reports by the United Nations' Food and Agriculture Organization (FAO) consider disease outbreaks as a significant constraint to the development of the aquaculture sector, with a global estimate (made by the World Bank in 1997) of disease losses in the range of US$3 billion per year [2] . Here, we focus on disease caused by luminescent vibrios (i.e. Vibrio harveyi and closely related bacteria such as Vibrio campbellii and Vibrio parahaemolyticus). These bacteria belong to the Gamma-proteobacteria and are Gram negative, usually motile rods [3] . Although these bacteria are commonly denoted as luminescent vibrios, not all strains are luminescent [4, 5] . Vibrio disease is described as vibriosis or bacterial disease, penaeid bacterial septicemia, penaeid vibriosis, luminescent vibriosis or red-leg disease [6] . Signs of disease include lethargy, tissue and appendage necrosis, slow growth, slow metamorphosis, body malformation, bolitas negricans, bioluminescence, muscle opacity and melanization [6] . In many cases, vibrios are opportunists, only causing disease when the host organism is immune suppressed or otherwise physiologically stressed, with the frequency of infection often being attributable to intensive culture and adverse environmental conditions [7] .
Almost all types of cultured animals can be affected by these bacteria (Table 1) . However, the most serious problems have been reported in penaeid shrimp culturing, and luminescent vibriosis has become a major constraint on shrimp production in South America and Asia [8] . The losses due to luminescent vibriosis in Indonesian hatcheries in 1991, for instance, have been reported to be as high as US$100 million [9] . In addition to affecting cultured animals, luminescent vibrios can also cause human infections, and related bacteria, such as Vibrio cholerae and Vibrio vulnificus, are known to be serious human pathogens [3] .
Antibiotics: the ambivalent solution Traditionally, antibiotics have been used in attempts to control bacterial disease in aquaculture. For example, Holmström et al. [10] reported that, of the 76 shrimp farmers they interviewed in Thailand, 56 used antibiotics. Most of those farmers used the antibiotics prophylactically, some on a daily basis. More than ten different antibiotics were used, including chloramphenicol, gentamycin, trimethoprim, tiamulin, tetracyclines, quinolones and sulfonamides. Moriarty [11] estimated the use of antibiotics in shrimp farm production in Thailand to be as high as 500-600 tonnes in 1994. In the Philippines, oxytetracycline, oxolinic acid, chloramphenicol, furazolidine, nitrofurans, erythromycin and sulfa drugs are commonly used to treat bacterial diseases [12] . Chemotherapy is also widely practiced in South America. In Mexico, for instance, the most commonly used antibiotics in shrimp farms are oxytetracycline, florfenicol, trimethoprim-sulfamethoxazole and, more recently, sarafloxacin and enrofloxacin [13] .
In view of the massive (mis)use of antibiotics in aquaculture, it is not surprising that many reports have mentioned (multiple) resistance of luminescent vibrios to several antibiotics (Table 2) . Consequently, currently, antibiotics are no longer effective in treating luminescent vibriosis. Karunasagar et al. [14] , for instance, reported mass mortality in black tiger shrimp (Penaeus monodon) larvae caused by V. harveyi strains with multiple resistance to cotrimoxazole, chloramphenicol, erythromycin and streptomycin. Of these antibiotics, the first two had been regularly used as prophylactics.
Apart from rendering treatments ineffective, the excessive (mis)use of antibiotics in aquaculture also constitutes a direct threat to human health and to the environment [7, 15] . The antibiotic resistance determinants that have emerged and/or evolved in the aquaculture environments have been shown to be transmitted by horizontal gene transfer to bacteria of the terrestrial environment, including animal and human pathogens. For example, the V. cholerae that caused the 1992 Latin-American epidemic of cholera seemed to have acquired antibiotic resistance as a result of coming into contact with antibiotic-resistant bacteria selected through the heavy use of antibiotics in the Ecuadorian shrimp industry [16] . The presence of residual antibiotics in commercialized aquaculture products constitutes another problem with respect to human health because this can lead to an alteration of the normal human gut microflora and can generate problems of allergy and toxicity [15] . Given the world-wide trade in aquaculture products, health problems related to antibiotic use in aquaculture are not limited to producing countries, but are also relevant to importing countries.
It might be clear from the above that global efforts are needed to promote more judicious use of antibiotics in aquaculture and that new strategies to control pathogenic bacteria are needed to make the industry more sustainable. Currently, measures to protect aquaculture animals from luminescent vibriosis without using antibiotics are being developed and tested. A holistic approach, which includes environment, host and pathogen, will probably be most sustainable ( Figure 1 ). In this new view on biocontrol, measures that prevent disease are the most important health management option [2]. However, it is not always economically feasible to culture the animals in the most optimal conditions, so there will always be a risk to infection and a need for effective biocontrol techniques. Alternative biocontrol measures directed towards luminescent vibrios that have recently been developed will be discussed throughout the following paragraphs; measures that aim at disease prevention and disease control at the level of the host are briefly discussed in Boxes 1 and 2.
Killing the vibrios: phage therapy
In the early 1920s, bacteriophages were discovered as viral infections of bacteria, and their value for antibacterial therapy and prophylaxis was almost immediately recognized. Surprisingly, phages were only relatively recently proposed as candidate therapeutics for aquaculture [17] . Several reports described the isolation of phages of luminescent vibrios, including lysogenic ones [18] and more recently also lytic phages [19] [20] [21] . We refer to previously published reviews for detailed information about phage therapy in general [17, 22, 23] . A major advantage of phage therapy is that non-target microbiota are not affected because the phages usually have a narrow host range [17] . However, many phages are strain specific rather than species specific [17] , so phages for use as biocontrol agents to treat luminescent vibriosis should be selected on their capability to infect a wide range of luminescent vibrios (Box 3).
Attempts to use phages to control luminescent vibriosis have only recently been reported. Shivu et al. [21] isolated seven phages from hatchery and creek water and tested their lytic spectrum against 183 V. harveyi strains originating from different geographical regions. They found that the phages lysed between 15% and 69% of the strains. None of the phages was able to infect other Vibrio species. The authors concluded that shrimp hatcheries would be a good source for the isolation of phages to be Review used as therapeutics. Vinod et al. [20] isolated a phage from shrimp farm water with lytic activity against all 50 V. harveyi isolates tested. The phage was tested both in a laboratory system and in a hatchery for its potential to protect P. monodon larvae. In the laboratory system, addition of the phage increased the survival of shrimp larvae infected with pathogenic V. harveyi by 45-55% and decreased luminescent bacterial counts by 2-3 log units after two days. In the hatchery trial, addition of the phage increased shrimp survival from 17% to 86% after 17 days. Interestingly, the phage treatment performed much better than daily addition of antibiotics (5 mg/l oxytetracyclin and 10 mg/l kanamycin), in which the shrimp survival was only 40%.
A constraint to the use of phages as therapeutics is that phages can transfer virulence factors [18, 19] . Hence, before using bacteriophages for therapy, it will be important to test whether they carry any virulence genes and whether they would be safe to use. A second important problem is the rapid development of resistance to phage attachment, which renders bacteria resistant to phage attack [23] . This problem could be overcome by applying cocktails of phages or by using phage components instead of intact phage.
Growth inhibition: short-chain fatty acids
Alternative strategies to control luminescent vibriosis could aim at inhibiting growth of the pathogens rather than killing them. Short-chain fatty acids (SCFAs) are known to inhibit the growth of pathogenic bacteria. Coated and uncoated SCFAs are currently used in commercial animal diets to control pathogens such as Salmonella [24] . Based on this, Defoirdt et al. [25] investigated whether these compounds could also be used to control luminescent vibriosis. In vitro tests showed that SCFA inhibited the growth of pathogenic luminescent vibrios in liquid medium. The effective growth-inhibitory SCFA concentrations were in the millimolar range and were dependent on the pH of the medium, with approximately ten times more SCFA needed per unit pH increase. Furthermore, in vivo challenge tests with gnotobiotic brine shrimp (Artemia franciscana) showed that 20 mM (2 g/l) of formic, acetic, propionic, butyric or valeric acid increased the survival of nauplii infected with a virulent V. campbellii strain from 20% to 45%, with no difference between the different SCFAs. In addition to this, Vá zquez et al. [26] recently reported that SCFAs (and not bacteriocins) are responsible for the inhibitory effect of lactic acid bacteria towards pathogenic vibrios. 
Box 1. Disease prevention
According to the FAO, disease prevention is the preferred health management option with respect to aquaculture diseases because preventive measures are most cost-effective [2]. Disease prevention can be achieved by improved management, including the prevention of the transmission of pathogens between farms (e.g. by quarantine [2]), and good hygiene (e.g. the disinfection of culture tanks, water and eggs [60] ). In many cases, aquaculture pathogens are opportunists, only causing disease when the host organism is immune suppressed or otherwise physiologically stressed [7], so eliminating stress is also an important factor that can reduce infections. This could be achieved by improving the water quality by water treatment [61] and bioaugmentation [62] and avoiding important stress factors such as high stocking densities, handling, temperature and salinity changes [60] . Furthermore, it seems that the feed quality also has an important impact on the susceptibility of cultured animals to luminescent vibriosis infections, so that animals that are in better physical health are more resistant to infection [63] . However, it is not always economically feasible to culture the animals in the most optimal conditions and give them the optimal feed, so there will always be a risk of infection and a need for effective biocontrol techniques.
Apart from inhibiting the growth of unwanted bacteria, SCFAs are also known to be a preferred source of energy for the colonic mucosa in mammals and to increase the health of the gastrointestinal epithelium [27] . It is not yet clear whether this is also true for aquatic animals, although Weltzien et al. [28] reported that brine shrimp can use the SCFA b-hydroxybutyrate as an energy source. This would mean that SCFAs not only function at the level of the pathogen, but also affect the host beneficially, and this might result in higher resistance to disease.
The fact that effective SCFA concentrations needed to protect brine shrimp from luminescent vibriosis were relatively high was attributed to the fact that brine shrimp are particle filter-feeders and cannot accumulate dissolved compounds [25] . Consequently, it was reasoned that the efficiency of these compounds might be increased by dosing them in particle form to the culture water. Based on literature reports mentioning that poly-b-hydroxyalkanoate polymers can be degraded into b-hydroxy SCFAs, and on the observation that b-hydroxybutyrate has the same positive effect towards infected brine shrimp as do other SCFAs, Defoirdt et al. [29] started to investigate whether poly-b-hydroxybutyrate (PHB) could be used as an elegant method to deliver SCFAs to the brine shrimp gut. The addition of 1000 mg/l commercial PHB particles (average diameter 30 mm) to the culture water offered a complete protection (no significant mortality when compared with uninfected nauplii) from the pathogenic V campbellii [29] . In a second study, it was shown that the addition of 10 7 cells/ml of PHB-containing Brachymonas bacteria (corresponding to 10 mg/l PHB) also completely protected the shrimp from the vibrios [30] . Although the exact mode of action is still unclear, it was hypothesized that the PHB polymer is (at least partially) degraded to b-hydroxybutyrate in the Artemia gut and that the release of this SCFA protects the shrimp from the pathogen.
Although these experiments should be repeated in other host systems, they suggest that PHB addition to the culture water or feed could be an interesting biocontrol measure. Indeed, PHB can be produced relatively easily [31] . Moreover, PHB production on waste streams (such as
Box 2. Vaccination and immunostimulation
Stimulation of host defenses can increase resistance to infectious disease by triggering specific immune responses (i.e. by vaccination) in addition to enhancing nonspecific defense systems (i.e. by immunostimulation) [64] . Immunostimulants receiving most attention comprise live bacteria, killed bacteria, glucans, peptidoglycans and lipopolysaccharide [65] . Vaccination refers to the administration of weakened or dead pathogenic bacteria or parts of them, with the aim of conferring long-lasting protection through immunological memory [66] . Vaccination requires primary challenge with antigen and relies on specific defense mechanisms which are traditionally believed only to exist in vertebrates; consequently, with respect to aquaculture, vaccination would only be possible in fish and not in crustaceans [65] . However, there has been some evidence that invertebrates also possess adhesion immunoglobulin superfamily molecules, which in mammals are known to be involved in adaptive immune responses [67] . We refer the reader to previously published reviews for more general information on immunostimulation [65, 68] and vaccination [66] in aquaculture.
The effects of vaccination against luminescent vibriosis in several fish species have been studied by different research groups, with promising results. Elevated antibody and Vibrio inhibitory activities, induction of immune memory and significantly increased survival of experimentally infected fish have been reported [69] [70] [71] . Unfortunately, vaccination is not possible in the case of fish larvae (which generally are most susceptible to disease) because it is practically infeasible to handle these small animals and, more importantly, because it is believed that fish larvae do not have the ability to develop specific immunity [68] .
Several reports have mentioned the use of immunostimulants to control luminescent vibriosis in shrimp, resulting in increased prophenoloxidase and phenoloxidase activities and hemocyte counts, and significantly increased survival after experimental infection with luminescent vibrios [72] [73] [74] . Although immunostimulation shows promise, there are some limitations that should be considered. First of all, immunostimulation might be too intense and can harm or even kill the host [65, 68] . Second, because there is no memory component involved, the response is likely to be short in duration, and hence immunostimulants will have to be administered repeatedly [64] . However, long-term administration of such agents seems to decrease the immunostimulant effect and does not always promote disease resistance [64, 65] . Possible solutions: Selection procedure: different modes of action, isolation from system in which they will be applied
Box 3. Summary of alternative biocontrol measures directed towards luminescent vibrios

Green water
Positive aspect: Control measure is part of the system (integrated aquaculture)
Negative aspect: Effectiveness in controlling disease still has to be proven Review molasses) could make this technique more cost-effective and sustainable [32] . Finally, it should be possible to produce PHB in situ in the culture water by adding carbonaceous compounds or by increasing the C:N ratio of the feed. Such practice, called biofloc technology, is currently getting more attention as a means to remove inorganic nitrogen from culture water through assimilation into microbial biomass, which can be used as feed source by the animals [33] . In addition to aquaculture applications, it might be interesting to evaluate polyhydroxyalkanoates as biocontrol agents in different host-microbe systems, such as, for instance, Salmonella infections in poultry and swine.
Virulence inhibition: disruption of quorum sensing Quorum sensing is a mechanism by which bacteria coordinate the expression of certain genes in response to the presence or absence of small signal molecules. V. harveyi uses a three-channel quorum-sensing system (Figure 2) . Phenotypes controlled by this quorum-sensing system include bioluminescence [34] and the production of several virulence factors, such as a type III secretion system [35] , extracellular toxin [36] and a siderophore [37] . Using quorum-sensing mutants, the V. harveyi quorum-sensing system was shown to regulate virulence of the bacterium towards gnotobiotic brine shrimp (A. franciscana) [38] and rotifers (Brachionis plicatilis) [39] . Halogenated furanones had been previously shown to disrupt acyl homoserine lactone (AHL)-and also autoinducer 2 (AI-2)-mediated signaling in Gram-negative bacteria [40, 41] . We recently found that the natural furanone (5Z)-4-bromo-5-(bromomethylene)-3-butyl-2(5H)-furanone blocks quorum-sensing-regulated gene expression in V harveyi by decreasing the DNA-binding activity of the quorum-sensing response regulator LuxR Vh [42] . The compound, at 20 mg/l, increased the survival of gnotobiotic brine shrimp nauplii challenged with several different luminescent vibrios, suggesting that virulence attenuation caused by quorum-sensing disruption is a general feature for luminescent vibrios [5] . Consistent with this, Tinh et al. [39] found that the furanone also neutralized the negative effect of V. harveyi BB120 towards gnotobiotic rotifers. Unfortunately, the furanone seemed to be toxic to both brine shrimp and rotifers [5, 39] .
Interestingly, quorum-sensing-disrupting compounds do not affect the growth of the vibrios [5,36] and thus do not pose any selective pressure. Consequently, the chance of resistance development will probably be smaller than for conventional antibiotics. Because quorum-sensing-disrupting compounds attenuate the virulence of pathogenic bacteria without affecting growth, they have been termed antipathogenic drugs, as opposed to antibacterial drugs [41] . Antipathogenic drugs target key regulatory systems in bacterial pathogens that regulate the expression of virulence factors. The fact that antipathogenic compounds are unlikely to pose a selective pressure for the development of resistance makes this concept highly attractive as a sustainable biocontrol strategy. Hence, it certainly would be worthwhile to try to synthesize new quorum-sensingdisrupting compounds (e.g. furanone analogues) that could be applied in practice to control luminescent vibriosis in aquaculture. These compounds could target signal production, signal detection or signal transduction. An alternative approach could be the application of signal molecule-inactivating bacteria. Bacteria that can degrade AHL-type signal molecules have been reported extensively in the literature [43] [44] [45] . Hence, it is of interest to investigate whether these types of bacteria could be used as a new type of probiotic (a live microbial adjunct that is beneficial to the host). Figure 2 . Quorum sensing in V. harveyi. V. harveyi has been shown to contain a three-channel quorum-sensing system. The first channel of the system is mediated by the harveyi autoinducer 1 (HAI-1), an AHL [57] . The second channel is mediated by AI-2, which is a furanosyl borate diester [58] . The chemical structure of the third autoinducer, called cholerae autoinducer 1 (CAI-1) is still unknown [59] . The LuxM, LuxS and CqsA enzymes synthesize the autoinducers HAI-1, AI-2 and CAI-1, respectively. These autoinducers are detected at the cell surface by the LuxN, LuxP-LuxQ and CqsS receptor proteins, respectively. (a) At low signal molecule concentration, the receptors autophosphorylate and transfer phosphate to LuxO through LuxU. Phosphorylation activates LuxO, which, together with s 54 , activates the production of small regulatory RNAs (sRNAs). These sRNAs, together with the chaperone Hfq, destabilize the mRNA encoding the response regulator LuxR Vh . Therefore, in the absence of autoinducers, the LuxR Vh protein is not produced. (b) In the presence of high concentrations of the autoinducers, the receptor proteins switch from kinases to phosphatases, which results in dephosphorylation of LuxO. Because dephosphorylated LuxO is inactive, the sRNAs are not formed and the response regulator LuxR Vh is produced. Signal molecule biosynthetic enzymes are shown in dark gray, signal receptors in light gray and proteins involved in signal transduction are shown as striped.
Finally, several human pathogens, including V. cholerae and V. vulnificus, have been found to contain a quorum-sensing system that is similar to the V. harveyi quorum-sensing system [46] ; consequently, quorum-sensing-disrupting techniques developed to control luminescent vibriosis might also be useful to treat infections caused by these human pathogens.
Antagonism: probiotics
Interest in the application of probiotics in aquaculture is fairly recent. Possible modes of action that have been mentioned in the literature for probiotics include (i) production of inhibitory compounds, (ii) competition for nutrients, (iii) competition for adhesion sites in the gastrointestinal tract, (iv) enhancement of the immune response and (v) production of essential nutrients such as vitamins and fatty acids, and enzymatic contribution to digestion [47, 48] . In addition to this, several authors also considered bacteria that improve the water quality by removing toxic inorganic nitrogen or by mineralizing organic matter as probiotics [47] . Based on the observations that bacterial cell-to-cell communication regulates the virulence of luminescent vibrios (see earlier), another mode of action of probiotics could be specific inhibition of virulence gene expression, for instance by disrupting cell-to-cell communication.
Most investigations on probiotics as biocontrol agents to treat luminescent vibriosis have been performed using Bacillus strains. In one of the earliest reports, Moriarty [49] found that the addition of a mixture of Bacillus strains that had been selected for the production of antibiotics against luminescent vibrios resulted in healthier prawns and lower numbers of luminescent vibrios in the pond water. Rengpipat et al. [50] found that the addition of Bacillus strain S11 to P. monodon infected with a pathogenic V. harveyi strain increased survival of the shrimp from 26% to 100% after ten days in laboratory-scale experiments. By contrast, later experiments showed only marginal increases in the survival of challenged shrimp in farm trials following addition of the Bacillus strain to the feed [51] . Vaseeharan and Ramasamy [52] showed that Bacillus subtilis strain BT23, isolated from shrimp culture ponds, produced a substance which inhibited the growth of V. harveyi. The addition of the Bacillus strain to the culture water of black tiger shrimp larvae resulted in a 90% decrease in accumulated mortality after 15 days.
Recently, Decamp et al. [53] reported some field data of the use of a commercial mixture of Bacillus strains, selected on their ability to inhibit pathogenic vibrios, to grow under hatchery conditions and to degrade waste products, on the performance of shrimp. In a Thai hatchery, the addition of the mixture to the culture water significantly improved the survival of P. monodon larvae and performed equally well as antibiotics. Similar results were obtained in a Brazilian hatchery with Litopenaeus vannamei larvae. Unfortunately, statistical analyses were not possible in the latter case owing to a lack of replicates.
The most important limitation to the use of probiotics is that in many cases they are not able to maintain themselves, and so need to be added regularly and at high concentrations [48] , which makes this technique less cost-effective. Moreover, probiotics that were selected in vitro based on the production of inhibitory compounds might fail to produce these compounds in vivo [47, 48] . Finally, the vibrios might develop resistance if the production of growth-inhibitory compounds is the only mode of action, as has occurred for numerous antibiotics. From the above, it seems to be clear that selection of probiotics needs to be performed carefully and that it might be advantageous to isolate candidate probiotics from the culture system(s) in which they will be applied because, in this case, the chance that they will be able to establish themselves is expected to be higher [47] . Moreover, it might be beneficial to select for probiotics with more than one antagonistic characteristic or to apply a mixture of probiotics with different modes of action, to maximize the chance of success. Alternatively, from a commercial point of view, it might be more advantageous to investigate whether probiotics that are already licensed for use in human or animal nutrition could be used instead of isolating new probiotics because licensing new probiotics for use in animal products is relatively expensive [54] and this might limit the commercial development of new probiotic products.
Antagonism: green water
In the so-called green water technique, shrimp are cultured in water from tilapia ponds, in which microalgae (such as Chlorella) grow abundantly. Tendencia and dela Peñ a [55] reported that V. harveyi disappeared from seawater containing Chlorella after two days of incubation. More recently, Lio-Po et al. [56] identified eight bacterial and 12 fungal isolates that were associated with green water and that had a promising growth-inhibitory effect towards luminescent V. harveyi. Interestingly, the majority of the luminescent Vibrio-inhibiting bacteria were isolated from tilapia skin mucus and gut. V. harveyi was also found to be inhibited by several microalgae associated with the green water. A 3-log decrease in luminous Vibrio counts was observed in coculture with the microalga Leptolyngbya sp. after one day of incubation. For the algae Chaetoceros calcitrans and Nitzchia sp., an even higher growth-inhibitory effect was noticed because luminous vibrios completely disappeared from the (co-)cultures after one and two days, respectively. Unfortunately, as far as we know, to date, no experimental data have been reported that demonstrate that green water or algae can indeed protect cultured animals against luminescent vibriosis disease. Moreover, more research will be needed to elucidate further the mechanism by which green water decreases luminescent Vibrio levels.
Conclusions and further perspectives
This review aimed at providing a critical evaluation of alternative measures that have recently been developed to control disease caused by V. harveyi and closely related bacteria. Techniques discussed include phage therapy, the use of SCFAs and polyhydroxyalkanoates, quorum-sensing disruption, probiotics and green water. Some of the techniques have only been studied recently and have only been tested in the laboratory (e.g. disruption of cell-to-cell communication), whereas others have a longer history, including farm trials (e.g. the application of probiotics).
Review
Each of the techniques has its advantages but also its limitations. In fact, none of them will probably be successful in all cases. Therefore, it is of importance to develop further all of these alternatives to construct a toolbox containing different sustainable biocontrol measures. A good biocontrol management strategy might then use different techniques in rotation to prevent resistance development. Alternatively, it might be valuable to determine which techniques are, and which are not, compatible with each other, to apply them together to maximize the chance of protecting the animals successfully. Finally, some of the alternative techniques that are being developed to control luminescent vibriosis in aquaculture might also be useful in treating human infections caused by related bacteria such as V. cholerae and V. vulnificus.
